Pediatric Lymphoma — Clinical Trials

MONDO:00036592 active·1 recruitingLast updated: Mar 19, 2026, 10:41 AM

Trial Landscape

Pediatric Lymphoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment3

Procedure1

By Phase

Phase 1

Phase 2

1 trials are observational or have no phase designation.

Sponsor Types

Academic/Other2Industry1

Top Sponsors

Cellectar Biosciences, Inc.

Trial Locations

United States2 trials

Australia1 trial

Canada1 trial

China1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 of 3 Trials

Phase 2Recruiting

NCT05253495

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

Sponsor:New York Medical College

United StatesStarted: Feb 2022Est. completion: Jun 2028Updated: Jun 2025

Phase 1Active, Not Recruiting

NCT03478462

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Sponsor:Cellectar Biosciences, Inc.

United StatesStarted: Apr 2019Est. completion: Feb 2027Updated: Mar 2026

Stay informed about clinical trials for Pediatric Lymphoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 10:41 AM